These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
392 related items for PubMed ID: 8553569
1. Molecular basis for the resistance of influenza viruses to 4-guanidino-Neu5Ac2en. Staschke KA, Colacino JM, Baxter AJ, Air GM, Bansal A, Hornback WJ, Munroe JE, Laver WG. Virology; 1995 Dec 20; 214(2):642-6. PubMed ID: 8553569 [Abstract] [Full Text] [Related]
5. The interaction of neuraminidase and hemagglutinin mutations in influenza virus in resistance to 4-guanidino-Neu5Ac2en. Blick TJ, Sahasrabudhe A, McDonald M, Owens IJ, Morley PJ, Fenton RJ, McKimm-Breschkin JL. Virology; 1998 Jun 20; 246(1):95-103. PubMed ID: 9656997 [Abstract] [Full Text] [Related]
6. Inhibition of replication of avian influenza viruses by the neuraminidase inhibitor 4-guanidino-2,4-dideoxy-2,3-dehydro-N-acetylneuraminic acid. Gubareva LV, Penn CR, Webster RG. Virology; 1995 Oct 01; 212(2):323-30. PubMed ID: 7571401 [Abstract] [Full Text] [Related]
7. Zanamivir. A potent and selective inhibitor of influenza A and B viruses. Aoki FY, Hayden FG. Clin Pharmacokinet; 1999 Oct 01; 36 Suppl 1():v-ix. PubMed ID: 10429834 [No Abstract] [Full Text] [Related]
8. Mutation in the influenza virus neuraminidase gene resulting in decreased sensitivity to the neuraminidase inhibitor 4-guanidino-Neu5Ac2en leads to instability of the enzyme. McKimm-Breschkin JL, McDonald M, Blick TJ, Colman PM. Virology; 1996 Nov 01; 225(1):240-2. PubMed ID: 8918554 [Abstract] [Full Text] [Related]
10. In vitro selection and characterisation of influenza B/Beijing/1/87 isolates with altered susceptibility to zanamivir. Barnett JM, Cadman A, Burrell FM, Madar SH, Lewis AP, Tisdale M, Bethell R. Virology; 1999 Dec 20; 265(2):286-95. PubMed ID: 10600600 [Abstract] [Full Text] [Related]
11. 2,3-didehydro-2,4-dideoxy-4-guanidino-N-acetyl-D-neuraminic acid (4-guanidino-Neu5Ac2en) is a slow-binding inhibitor of sialidase from both influenza A virus and influenza B virus. Hart GJ, Bethell RC. Biochem Mol Biol Int; 1995 Jul 20; 36(4):695-703. PubMed ID: 8528132 [Abstract] [Full Text] [Related]
12. Generation and characterization of variants of NWS/G70C influenza virus after in vitro passage in 4-amino-Neu5Ac2en and 4-guanidino-Neu5Ac2en. McKimm-Breschkin JL, Blick TJ, Sahasrabudhe A, Tiong T, Marshall D, Hart GJ, Bethell RC, Penn CR. Antimicrob Agents Chemother; 1996 Jan 20; 40(1):40-6. PubMed ID: 8787876 [Abstract] [Full Text] [Related]
13. Catalytic and framework mutations in the neuraminidase active site of influenza viruses that are resistant to 4-guanidino-Neu5Ac2en. Gubareva LV, Robinson MJ, Bethell RC, Webster RG. J Virol; 1997 May 20; 71(5):3385-90. PubMed ID: 9094607 [Abstract] [Full Text] [Related]
14. A single sequence change destabilizes the influenza virus neuraminidase tetramer. Colacino JM, Chirgadze NY, Garman E, Murti KG, Loncharich RJ, Baxter AJ, Staschke KA, Laver WG. Virology; 1997 Sep 15; 236(1):66-75. PubMed ID: 9299618 [Abstract] [Full Text] [Related]